Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new publication citation for Chen et al., J Thorac Oncol 2025 was added to the Publications section and the previous version of the citation was removed.
    Difference
    0.1%
    Check dated 2025-12-02T11:41:05.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications section now notes that entries are automatically filled from PubMed, and the page revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:25:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the ClinicalTrials.gov page was removed, with the rest of the trial details remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:50:08.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T20:37:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Publications now appear under the Publications section, including the Chen MF et al. article on amivantamab plus lazertinib (online ahead of print).
    Difference
    0.3%
    Check dated 2025-10-27T14:11:01.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T04:31:13.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.